Results 321 to 330 of about 23,125,138 (369)
Some of the next articles are maybe not open access.

Recombinant Interleukin‐2

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
Recombinant interleukin (IL)‐2 is a newly approved immunoregulatory protein produced by lymphocytes that exhibits a wide range of immunologic effects. It is a true biologic response modifier in that is has no known direct antitumor activity, but mediates its cytotoxicity through activation of effector cells including T cells, natural killer cells, and ...
J K, Bruton, J M, Koeller
openaire   +2 more sources

Regulation of Interleukin 2 Receptor Expression by Interleukin 2

Scandinavian Journal of Immunology, 1986
The regulatory influence of Interleukin 2 (IL‐2) on the expression of IL‐2 receptors (IL.‐2R) was studied using long‐term cultured T‐cell lines and recombinant IL‐2 (r‐IL‐2). Three T‐cell lines with different growth requirements were used as model systems: insulin‐specific BK‐BI‐1.2 cells express IL‐2R transiently after antigenic restimulation ...
A B, Reske-Kunz   +3 more
openaire   +2 more sources

Interleukin-2

Annual Review of Immunology, 1984
In the past year there have been significant advances in understanding the role of interleukin-2. Its role in the activation of T cells by antigen-presenting cells, the structure-activity relationships between interleukin-2 and its receptor and the subsequent signaling have all become clearer.
openaire   +4 more sources

Interleukin-2

The American Journal of Nursing, 1987
P F, Jassak, P L, Spiewak
openaire   +2 more sources

Interleukin-2

Reactions Weekly, 2013
Howard L. Kaufman   +2 more
openaire   +2 more sources

Interleukin-2

DMW - Deutsche Medizinische Wochenschrift, 2008
R, Fink, H, Dancygier
openaire   +2 more sources

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

New England Journal of Medicine, 1987
S. Rosenberg   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy